You are here

  • Home
  • Archive
  • Volume 5, Issue 4
  • Losartan reduced stroke and new onset diabetes more than atenolol in essential hypertension with signs of left ventricular hypertrophy

Article Text

Article menu
Download PDFPDF
Treatment
Losartan reduced stroke and new onset diabetes more than atenolol in essential hypertension with signs of left ventricular hypertrophy

https://doi.org/10.1136/ebn.5.4.112

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: Merck.

    • For correspondence: Professor B Dahlöf, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden. bdahlof{at}scandinaviancri.se

    • A modified version of this abstract appears in ACP Journal Club.